ArticleJournal of medicinal chemistry2026

A Potent and Selective Quinolone-Based PTPN22 Inhibitor with Improved Immunotherapeutic Activity.

Jianping Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.